This article is authored by Dr K Madan Gopal, senior health sector expert and former senior consultant, health, NITI Aayog.

India this week approved its first vaccine against dengue, a milestone in the country's decades-long struggle with a mosquito-borne disease that infects thousands and kills hundreds every year. Dengue ...

TOKYO: Meiji Seika Pharma-owned Medreich Pharma is eyeing inorganic growth and more generics supply from India, while the ...

India has approved its first dengue vaccine as cases of the mosquito-borne disease surge in South Asia. Japan's Takeda Pharmaceutical's dengue vaccine QDENGA has been approved by India's drug ...

India approves its first dengue vaccine, Takeda's Qdenga, effective against all four dengue strains and usable without pre-vaccination screening, aiming to combat rising dengue cases nationwide.

India has approved its first dengue vaccine, QDENGA, in a step against a disease that has become an increasingly large public health challenge in the country. The approval comes as dengue cases in the ...

India approves Takeda's QDENGA dengue vaccine for ages 4-60, offering protection against all virus serotypes without prior screening.

Takeda's QDENGA has been approved for people aged 4–60, offering a new prevention tool as dengue cases and the wider disease burden remain a public health challenge.

India has approved its first vaccine to help prevent dengue, marking a significant step in tackling one of the country's most widespread mosquito-borne diseases. Japanese biopharmaceutical company ...

A study suggests the hexavalent vaccine could enhance India's immunisation efficiency by reducing injections and easing healthcare burdens.

India stands at a defining moment in its life sciences journey. Having built formidable strengths across pharmaceuticals, ...